Literature DB >> 22915799

HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.

Prabhjeet K Phalora1, Nathan M Sherer, Steven M Wolinsky, Chad M Swanson, Michael H Malim.   

Abstract

The APOBEC3 cytidine deaminases play a critical role in host-mediated defense against exogenous viruses, most notably, human immunodeficiency virus type-1 (HIV-1) and endogenous transposable elements. APOBEC3G and APOBEC3F interact with numerous proteins that regulate cellular RNA metabolism, including components of the RNA-induced silencing complex (RISC), and colocalize with a subset of these proteins to mRNA processing bodies (P bodies), which are sites of mRNA translational repression and decay. We sought to determine the role of P bodies and associated proteins in HIV-1 replication and APOBEC3 antiviral activity. While we established a positive correlation between APOBEC3 protein incorporation into virions and localization to P bodies, depletion of the P-body components DDX6 or Lsm1 did not affect HIV-1 replication, APOBEC3 packaging into virions or APOBEC3 protein mediated inhibition of HIV-1 infectivity. In addition, neither HIV-1 genomic RNA nor Gag colocalized with P-body proteins. However, simultaneous depletion of multiple Argonaute family members, the effector proteins of RISC, could modestly increase viral infectivity. Because some APOBEC3 proteins interact with several Argonaute proteins, we also tested whether they could modulate microRNA (miRNA) activity. We found no evidence for the specific regulation of miRNA function by the APOBEC3 proteins, though more general effects on transfected gene expression were observed. In sum, our results indicate that P bodies and certain associated proteins do not regulate HIV-1 replication or APOBEC3 protein antiviral activity. Localization to P bodies may therefore provide a means of sequestering APOBEC3 enzymatic activity away from cellular DNA or may be linked to as yet unidentified cellular functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915799      PMCID: PMC3486339          DOI: 10.1128/JVI.00595-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  108 in total

1.  A role for the P-body component GW182 in microRNA function.

Authors:  Jidong Liu; Fabiola V Rivas; James Wohlschlegel; John R Yates; Roy Parker; Gregory J Hannon
Journal:  Nat Cell Biol       Date:  2005-11-13       Impact factor: 28.824

2.  General translational repression by activators of mRNA decapping.

Authors:  Jeff Coller; Roy Parker
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Virus-like particles of the Ty3 retrotransposon assemble in association with P-body components.

Authors:  Nadejda Beliakova-Bethell; Carla Beckham; Thomas H Giddings; Mark Winey; Roy Parker; Suzanne Sandmeyer
Journal:  RNA       Date:  2006-01       Impact factor: 4.942

Review 4.  Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors.

Authors:  Bryan R Cullen
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release.

Authors:  Jez G Carlton; Monica Agromayor; Juan Martin-Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-18       Impact factor: 11.205

6.  Host deadenylation-dependent mRNA decapping factors are required for a key step in brome mosaic virus RNA replication.

Authors:  Antonio Mas; Isabel Alves-Rodrigues; Amine Noueiry; Paul Ahlquist; Juana Díez
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.

Authors:  Véronique Zennou; Paul D Bieniasz
Journal:  Virology       Date:  2006-02-07       Impact factor: 3.616

8.  Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.

Authors:  Molly OhAinle; Julie A Kerns; Melody M H Li; Harmit S Malik; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

9.  Changes in microRNA expression profiles in HIV-1-transfected human cells.

Authors:  Man Lung Yeung; Yamina Bennasser; Timothy G Myers; Guojian Jiang; Monsef Benkirane; Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2005-12-28       Impact factor: 4.602

10.  Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.

Authors:  Michael J Wichroski; G Brett Robb; Tariq M Rana
Journal:  PLoS Pathog       Date:  2006-05-12       Impact factor: 6.823

View more
  32 in total

1.  APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.

Authors:  Daniel J Salamango; Jordan T Becker; Jennifer L McCann; Adam Z Cheng; Özlem Demir; Rommie E Amaro; William L Brown; Nadine M Shaban; Reuben S Harris
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

2.  Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.

Authors:  Brook C Barajas; Motoko Tanaka; Bridget A Robinson; Daryl J Phuong; Kasana Chutiraka; Jonathan C Reed; Jaisri R Lingappa
Journal:  PLoS Pathog       Date:  2018-04-17       Impact factor: 6.823

3.  Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus.

Authors:  Jonathan C Reed; Nick Westergreen; Brook C Barajas; Dylan T B Ressler; Daryl J Phuong; John V Swain; Vishwanath R Lingappa; Jaisri R Lingappa
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

4.  Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies.

Authors:  Mariana Marin; Sheetal Golem; Susan L Kozak; David Kabat
Journal:  Virus Res       Date:  2015-11-25       Impact factor: 3.303

5.  Subcellular Localization of HIV-1 gag-pol mRNAs Regulates Sites of Virion Assembly.

Authors:  Jordan T Becker; Nathan M Sherer
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

6.  Cytoplasmic RNA Granules and Viral Infection.

Authors:  Wei-Chih Tsai; Richard E Lloyd
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

7.  Manipulation of cellular processing bodies and their constituents by viruses.

Authors:  Asit K Pattnaik; Phat X Dinh
Journal:  DNA Cell Biol       Date:  2013-04-25       Impact factor: 3.311

8.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

9.  GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.

Authors:  Kazuhiko Maeda; Sarah Ameen Almofty; Shailendra Kumar Singh; Mohammed Mansour Abbas Eid; Mayuko Shimoda; Terumasa Ikeda; Atsushi Koito; Phuong Pham; Myron F Goodman; Nobuo Sakaguchi
Journal:  J Immunol       Date:  2013-11-06       Impact factor: 5.422

10.  Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.

Authors:  Taisuke Izumi; Ryan Burdick; Mayu Shigemi; Sergey Plisov; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.